mgr Wioletta Makuch
Strona główna
/
Instytut
/
Pracownicy
/
mgr Wioletta Makuch
mgr Wioletta Makuch
Dokonania naukowe
- Publikacje
Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies
Autorzy: Katarzyna Ciapała, Katarzyna Pawlik, Agata Ciechanowska, Wioletta Makuch, Joanna Mika
DOI: 10.1007/s43440-024-00671-9
Date: 2024-12-01
Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
Autorzy:
DOI: 10.3389/fimmu.2020.615327
Date: 2020-12-21
Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain
Autorzy:
DOI: 10.1016/j.neuropharm.2020.108232
Date: 2020-11-01
Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain
Autorzy:
DOI: 10.1007/s43440-020-00137-8
Date: 2020-10-01
Novel bifunctional hybrid compounds designed to enhance the effects of opioids and antagonize the pronociceptive effects of nonopioid peptides as potent analgesics in a rat model of neuropathic pain
Autorzy:
DOI: 10.1097/j.pain.0000000000002045
Date: 2020-09-23
CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain
Autorzy:
DOI: 10.1016/j.ejphar.2020.173166
Date: 2020-08-01
Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses
Autorzy:
DOI: 10.1016/j.intimp.2020.106540
Date: 2020-07-01
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain
Autorzy: Katarzyna Pawlik, Anna Piotrowska, Klaudia Kwiatkowski, Katarzyna Ciapała, Katarzyna Popiolek‐Barczyk, Wioletta Makuch, Joanna Mika
DOI: 10.1111/imm.13172
Date: 2020-04-01
Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury
Autorzy:
DOI: 10.3389/fimmu.2019.02198
Date: 2019-09-26
Functional characterization of a novel opioid, PZM21, and its influence on behavioural responses to morphine.
Autorzy:
DOI: 10.1111/bph.14805
Date: 2019-07-26